Are You Ready to See the Changes? A Comparison of MV Capital Management's Q4 2022 and Q1 2023 Holdings

Investors are always on the lookout for the latest insights on how their portfolio is performing, and the quarterly 13F filings give such insights. MV Capital Management's latest filings are out, and it is time to take a closer look at how the company's Q4 2022 holdings compare with those of Q1 2023. In this blog post, we will analyze the changes and try to find out what they mean for the fund's performance moving forward.

Introduction

MV Capital Management, Inc. is a California-based investment management firm that specializes in providing investment advisory services to high net worth individuals and institutional clients. The company manages several funds and employs a long-term, value-focused investment strategy. Their latest 13F filings, covering the period from Q4 2022 to Q1 2023, have just been released, and we can see how their holdings have changed during this time.

Main Body

TFLO, ISHARES TR is one of the largest holdings of MV Capital Management, with a 22.1% decrease in shares from Q4 2022 to Q1 2023. It is interesting to note that the decrease was not accompanied by a significant change in value. This indicates that the price per share remained relatively constant during this period, and the change was mainly due to a reduction in the number of shares held.

IWD, ISHARES TR is another significant holding of MV Capital Management, with a slight increase of 4.9% in shares from Q4 2022 to Q1 2023. The company's Q4 2022 value was $53.813 million, while the Q1 2023 value was $56.424 million. This indicates that the value of the holding increased during this period due to the price per share going up. The company's investment in IWF, ISHARES TR also saw a significant increase of 17% in value, reflecting the growth of the underlying assets.

Another interesting observation is the increase in the holdings of some of the companies that have been adversely affected by the pandemic. For instance, ABBVIE INC, which specializes in research-based biopharmaceuticals, saw an increase of 15.8% in shares held by MV Capital Management. Abbott Labs, another healthcare company, saw an increase in shares of 7.2%, with a corresponding increase in value. The management firm's position in NVIDIA CORPORATION also saw a massive increase of 103.6% in value, indicating its confidence in the company's ability to capitalize on the growing demand for technology products.

It is also worth noting that the firm's holdings in some of the companies in the financial sector have taken a hit, with CITIZENS FINL GROUP INC, losing the most significant percentage decrease in shares held (21.8%). Other financial companies, such as JPMORGAN CHASE & CO and CME GROUP INC, also experienced slight reductions in shares held.

Conclusion

MV Capital Management's Q4 2022 and Q1 2023 13F filings provide insightful information on the company's portfolio changes. Throughout the period, the company's holdings performance was distinguished by both long-term portfolio decisions and short-term tactics. While the price per share was relatively constant, some holdings showed varying degrees of changes in their values, reflecting the underlying asset's growth. Other holdings were affected by factors such as pandemic effects and political changes, which are essential considerations when making investment decisions. Overall, the filings provide valuable insights into the company's investment strategy and may be helpful in assessing the company's future performance. As always, investors should consult a financial advisor before making any investment decisions.